en

PRODUCT DETAIL

ASPAVELI 1 080 mg infúzny roztok

Code 9366D
MA number EU/1/21/1595/001
Product Form: sol inf 1x20 ml/1080 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA54 Pegcetacoplan
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 13.12.2021
Validity: 13.12.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.03.2023
eu-flag.png sk-flag.png